Showing results (111-120 of 175) with videos related to
Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|February 26, 2023
Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and AcarboseJing Wang, Hua Liang, You Wang, et al.BMC Oral Health|November 8, 2024
Neutrophil extracellular traps in the cross-talk between periodontitis and chronic kidney diseaseShucheng Hu, Ruhan Yang, Wenying Yang, et al.BMC Oral Health|April 16, 2024
Expression patterns of mechanosensitive ion channel PIEZOs in irreversible pulpitisWenying Yang, Lu Lin, Shucheng Hu, et al.Diabetes, Obesity & Metabolism|September 23, 2020
Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre, randomized, double-blind, placebo-controlled phase 3a clinical trialYing Shuai, Gangyi Yang, Qiu Zhang, et al.Journal of Diabetes|May 15, 2014
Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitusWenying Yang, Xiaoping Xing, Xiaofeng Lv, et al.Computer Methods and Programs in Biomedicine|March 9, 2020
Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetesLulu Song, Changqing Liu, Wenying Yang, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trialWenying Yang, Jie Liu, Zhongyan Shan, et al.Journal of Proteome Research|February 26, 2025
Clinical Response Characteristics of Salivary Proteins in the Management Strategy of Diabetes-Associated PeriodontitisShuyuan Jia, Qin Liang, Yanling Zhang, et al.Plos One|December 31, 2013
Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter studyJian Zhou, Yifei Mo, Hong Li, et al.Diabetes, Obesity & Metabolism|July 26, 2017
Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trialWenying Yang, Kyungwan Min, Zhiguang Zhou, et al.Pageof 18